IMR Press / EJGO / Special Issues / 1586238723464

BRCA and Ovarian Cancer

Section: Ovarian Cancer
Submission deadline: 30 April 2021
Special Issue Editors
Gennaro Cormio, MD
Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari “Aldo Moro”, Piazza Giulio Cesare 11, Bari, Italy
Interests: Vulvar Cancer; Ovarian cancer
Special Issue Information

Dear Colleagues,

Ovarian cancer is the fifth cause of cancer death in women worldrwide. The role of BRCA 1-1 genes mutation ha resulted in a significant improvement in scientific research in this field. Brca mutation has been reported in about 15 to 30 % of ovarian cancer patients in different geographic areas. It has a probably a prognostic role but particularly a fundamental predictive role of response to PARP inhibitors and may be also other compounds. A number of researches are actually ongoing in order to confirm the potential role of this mutation in surgical and medical management of ovarian cancer. Moreover the role of BRCA gene mutation detection in the general population is fundamental in order to achieve a potential genetic prevention of ovarian cancer. A number of potential strategies are studied also concerning reproductive medicine and BRCA 1-2 mutation. The aim of this special issue of the Journal is to collect new insights on this fascinating topic.

Prof. Dr. Gennaro Cormio

Guest Editor

BRCA 1-2 mutation
Ovarian cancer
Prophylactic surgery
Reproductive medicine
Hormonal treatment
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (4 Papers)
Open Access Review
BRCA-guided therapy of ovarian cancer
Panagiota Economopoulou, Ioannis Kotsantis, Aristotelis Bamias
Eur. J. Gynaecol. Oncol. 2021, 42(3), 405–413;
(This article belongs to the Special Issue BRCA and Ovarian Cancer)
Open Access Review
Prophylactic mastectomy and ovariectomy—a religious perspective
Bartosz Kasprzak, Przemysław Zgórecki
Eur. J. Gynaecol. Oncol. 2021, 42(3), 414–417;
(This article belongs to the Special Issue BRCA and Ovarian Cancer)
Open Access Review
Oral contraception use in BRCA gene mutation carriers: information for counselling in routine clinical practice
Chiara Cassani, Francesca Zanellini, Cristina Angela Camnasio, Diana Pettinato, ... Rossella Elena Nappi
Eur. J. Gynaecol. Oncol. 2021, 42(3), 441–449;
(This article belongs to the Special Issue BRCA and Ovarian Cancer)
Open Access Review
New treatment strategy for ovarian cancer with a BRCA gene mutation
Tadahiro Shoji, Kotoka Kikuchi, Hayato Kogita, Nanako Jonai, ... Tsukasa Baba
Eur. J. Gynaecol. Oncol. 2021, 42(1), 1–9;
(This article belongs to the Special Issue BRCA and Ovarian Cancer)
Back to top